reported that miR-22 binds directly to Sirt 1 and enhances Sirt 1 expression. [18] [19] [20] In glioblastoma cells, miR-22 inhibits cell proliferation, motility, and invasion by targeting Sirt 1. 19 However, the role of miR-22 in diabetic cardiomyopathy is unknown. In this study, we assessed whether miR-22 could attenuate oxidative stress injury and apoptosis and improve cardiac function via Sirt 1.
| METHODS

| Animals
All investigations were performed in accordance with the proto- ported. 12 Male C57BL/6 mice (20-25 g) were from the Experimental Animal Center of Wuhan University (Wuhan, China). Forty male C57BL/6 mice were randomly divided into 4 groups, the control group (rAAV-green fluorescent protein (GFP)), the miR-22 overexpression group (rAAV-miR-22), the diabetes mellitus group (DM+ rAAV-GFP, which developed DCM), and the DM mice with overexpression of miR-22 group (DM + rAAV-miR-22). All animals were raised under standard laboratory conditions (12-hour light, 12-hour dark cycle, 22-25°C room temperature, and 45%-55% relative humidity). Mice were treated with intravenous injection of corresponding rAAV (1 × 10 11 virion particles), respectively. Two weeks after rAAV injection, mice were treated with streptozotocin.
| Material and reagents
The chemicals and reagents were from Sigma Company (St. 
| Oral glucose tolerance test
The oral glucose tolerance test (OGTT) was conducted to diagnose diabetes. After fasting for 12 hours overnight, the blood samples were collected from the tail vein. 6 Following blood collection, the mice were fed with 50% glucose through a gastric tube at a dose of 2 g/kg body weight. After 30, 60, 90, and 120 minutes, the blood samples were collected. Then, the samples were isolated after centrifuging at 1600 g for 10 minutes. The blood glucose level was determined using an AEROSET Clinical Chemistry System (Abbott Laboratories, Abbott Park, Illinois).
| Cell culture
The H9c2 embryonic cardiac myoblast cell line (H9c2 cell) was purchased from the China Center for Type Culture Collection (Wuhan, China). The cells were cultured in DMEM-high glucose medium supplemented with 10% FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin and incubated at 37°C in a humidified atmosphere containing 5% CO 2 . These oligonucleotides (miRNA mimics, siRNAs, pcDNA-Sirt 1) were transfected into H9c2 cells using Lipo 2000 transfection kit.
Twenty-four hours after transfection, glucose was added to the cells at a final concentration of 25 mmol/L.
| Western blotting analysis
Western blot analysis was performed as previously described. 3, 6 We used primary antibodies against Sirt 1, GRP 78, ATF3, CHOP, Bax, Bcl-2, cleaved caspase-9, caspase-9, cleaved caspase-3, caspase-3, and the β-actin,as well as appropriate secondary antibodies. All groups were then normalized to their respective controls, and bar graphs represent quantification of at least 3 independent experiments. 
| Malondialdehyde, superoxide dismutase and reactive oxygen species detection
| Cardiac histological analysis
After the animals were killed, the hearts were separated, rinsed 3 times in PBS and then fixed in 4% paraformaldehyde. The samples were then digested with proteinase K and incubated with TUNEL liquid for 90 minutes at 37°C. The reaction was terminated by adding a sodium citrate solution. The samples were then incubated with anti-HRP antibody for 15 minutes, then washed with PBS, and stained with DAB. The samples were observed and photographed at 400× on a light microscope, and the apoptosis rate was calculated as previously described. 12 
| Flow cytometry analysis
The rates of cell apoptosis were analyzed by flow cytom- 
| Real-Time qPCR
| Echocardiography and in vivo hemodynamics
We perform echocardiography examination of diabetic mice 12 weeks after HF-STZ administration. The cardiac function of the animals was evaluated through a VIVO 2100 echocardiography machine (VisualSonics, Toronto, Canada). After anesthetization, echocardiographic analysis was performed as described previously. 21 The hemodynamics of the heart were evaluated by the Millar pressure volume system (MPVS) (AD instruments, New South Wales, Australia), which has been described previously. 
| Statistical analysis
The data are presented as mean ± SEM or mean ± SD. Student's t tests and ANOVAs were performed to identify statistically significant differences among different treatment group, as appropriate. In all cases, P < .05 was considered statistically significant.
| RESULT
| miR-22 is downregulated in the hearts of diabetic mice
Streptozotocin (STZ) and high-fat diet were used to induce diabetes, as described previously. 12 The blood glucose of animals that received STZ was higher than the control group ( Figure 1A ), indicating that diabetes mellitus had developed.
Real-time PCR was performed to detect the expression level of miR-22. A significantly decreased level of miR-22 was detected in the heart of diabetic mice, in compared to control group ( Figure 1B ).
F I G U R E 2 Overexpression of miR-22 improved cardiac function in diabetic cardiomyopathy. (A) The oral glucose tolerance test (OGTT); (B)
Relative miR-22 expression in the heart from wild-type mice and miR-22 transgenic mice fed normal diet or HF-STZ diet; **P < .01 vs rAAV-GFP; *P < .05 vs rAAV-GFP; #P < .05 vs DM + rAAV-GFP; (C) The left ventricular ejection fraction (LVEF) was evaluated by echocardiography; (D) The fraction shortening (FS) was evaluated by echocardiography. (E-J) The hemodynamic function was evaluated by the cardiac catheter system, including the left ventricular end-diastolic pressure (LVEDP), as well as the Dp/dt maximum and minimum. All data are presented as the mean ± SEM. (H) Relative BNP expression was detected by real-time PCR; (I-J) TUNEL staining of heart sections from mice with different treatment. *P < 0.05 vs rAAV-GFP, **P < .01 vs rAAV-GFP; #P < .05 vs DM + rAAV-GFP 
| Overexpression of miR-22 improves cardiac dysfunction in diabetic cardiomyopathy
In the in vivo study, recombinant adeno-associated virus (rAAV)-miR-22 was used to upregulate the expression of miR-22 in mice. The blood glucose of STZ-treated mice was higher than the control group (Figure 2A ), indicating that diabetes mellitus had developed. However, overexpression of miR-22 ameliorated the elevated blood glucose.
Real-time PCR verified that the level of miR-22 was markedly reduced in the hearts of diabetic mice but was significantly increased in the mice treated with rAAV-miR-22 ( Figure 2B ). After 12 weeks, echocardiograph examination of the diabetic mice revealed a significantly reduced ejection fraction (EF), which was attenuated by overexpression of miR-22 ( Figure 2C) . A similar effect was observed for fraction shortening (FS) ( Figure 2D ). The results from the cardiac catheter indicated that overexpression of miR-22 improved the left ventricular end-diastolic pressure (LVEDP), ventricular contractility (dp/dt) maximum and dp/ dt minimum, which were impaired in diabetic mice ( Figure 2E-G) .
Consistently, rAAV-miR-22 reduces brain natriuretic peptide (BNP) mRNA expression in the hearts of diabetic mice, which was an indicator of cardiac dysfunction ( Figure 2H ). These findings provided evidence of cardiac dysfunction and severely altered heart structure in the dia- 
-related protein expression in diabetic cardiomyopathy. The ratios Bax/Bcl-2, cl-casp-3/casp-3, and cl-casp-9/casp-9 were markedly upregulated in the hearts of diabetic mice ( Figure 3D ). The results presented in Figure 3D showed that overexpression of miR-22 significantly inhibited the increases in the Bax/Bcl-2, cl-casp-3/casp-3, and cl-casp-9/casp-9 ratios in the hearts of diabetic mice. However, transfection with miR-NC did not exert anti-apoptotic effect ( Figure 4G ). Moreover, miR-22 significantly inhibited the increases in the Bax/Bcl-2, cl-casp-3/casp-3, and cl-casp-9/casp-9 ratios in HG-treated H9c2 cells ( Figure 4H ).
| Sirt 1 is a direct target of miR-22 in H9c2 cells
Bioinformatics analysis using TargetScan 6.2 software was used to search for potential targets of miR-22 to explain its function in H9c2 cells. Sirt 1, a key regulator of metabolism and longevity, was identified as a potential miR-22 target ( Figure 5A ). Aligning human, rat, and mouse Sirt 1 3′-UTRs revealed that the predicted miR-22 binding sites were highly conserved, which suggested that these sites may be important 
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| Upregulation of Sirt 1 has similar effects as overexpression of miR-22
To imitate the function of Sirt 1, H9c2 cells were transfected with pcDNA-Sirt 1. Western blot analysis indicated that expression of Sirt 1 increased significantly in H9c2 cells after 24 hours transfected with pcDNA-Sirt 1 ( Figure 6A ). The CCK-8 assay revealed that upregulation of Sirt 1 improved the viability of HG-treated H9c2 cells ( Figure 6B ).
Overexpression of Sirt 1 evidently inhibited the increase in ROS and
MDA levels and restored the SOD level compared to HG-only or pcDNA-3.1 group (Figure 6C-E) . In addition, overexpression of Sirt 1 also significantly inhibited the increases in the Bax/Bcl-2, cl-casp-3/ casp-3, and cl-casp-9/casp-9 ratios in HG-treated H9c2 cells ( Figure 6F ). 
| Sirt 1 is essential for protective effect of miR-22 on HG-induced oxidative stress injury in H9c2 cells
| DISCUSSION
In the present study, we found that high glucose could reduce the cell viability of H9c2 cells, induce oxidative stress injury and apoptosis, and cause cardiac dysfunction and damaged heart structure in diabetic mice. The mRNA level of miR-22 decreased evidently in the heart of diabetic mice and HG-treated H9c2 cells. In the in vivo 
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Bax/Bcl-2 levels 16 In our study, overexpression of miR-22 attenuated oxidative stress injury and apoptosis in diabetic mice.
Sirt 1 is a crucial NAD (+)-dependent deacetylase that has important roles in various biological processes such as metabolism, stress response, and aging. 17, 19 Upregulation of Sirt 1 could exert automatic protection effect against varied kinds of disease pathophysiologies including diabetes, obesity, cardiomyocyte hypertrophy, and apoptosis. 20 Sirt 1 can alleviate AngII-induced cardiomyocyte hypertrophy and apoptosis by regulating several important survival genes and pro-apoptotic genes. 27 Upregulation of Sirt 1 might also provide positive metabolic outcomes, but Sirt 1-deficient mice have a shortened lifespan with a pronounced metabolic defect. 28 In our study, miR-22 enhanced the expression of Sirt 1 and downregulated the expression of endoplasmic reticulum stress-related proteins and apoptosis. However, miR-22 failed to inhibit the expression of endoplasmic reticulum stress-related proteins and apoptosis in HG-treated H9c2 cells after knockdown of Sirt 1.
In conclusion, the results of the present study confirm that the protective effect of miR-22 against HG-induced cardiovascular damages involves the attenuation of ER stress injury via Sirt 1. This study identifies that miR-22 may be a potential therapeutic target for diabetic patients with cardiac insufficiency.
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